We evaluated the relationship between imaging biomarker by GMV changes and blood biomarkers by plasma levels of HO-1, PPIA, and IRE1 in the groups of cognitively normal (CN), amnestic mild cognitive impairment (MCI), and AD participants. Our study demonstrates that subjects with AD have lower circulating levels of HO-1 than subjects with MCI and the plasma HO-1 levels were positively associated with the global GMV. Considering the potential roles of each enzyme in pathogenesis of AD, the plasma circulating levels of these enzymes possibly reflect the pathological changes of the brain in AD and would be candidates for blood-based biomarkers.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords